Cargando…

Metformin Therapy and Breast Cancer Incidence in the Ha’il Region

Background: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Mhdia, Muqbel, Taif, Abduallh, Ahad, Alanazi, Shuruq, Khalifa, Nasrin E., Khojali, Weam M. A., Elagib, Halima Mustafa, Hussein, Weiam, Abdallah, Marwa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914021/
https://www.ncbi.nlm.nih.gov/pubmed/36766896
http://dx.doi.org/10.3390/healthcare11030321
_version_ 1784885566957944832
author Osman, Mhdia
Muqbel, Taif
Abduallh, Ahad
Alanazi, Shuruq
Khalifa, Nasrin E.
Khojali, Weam M. A.
Elagib, Halima Mustafa
Hussein, Weiam
Abdallah, Marwa H.
author_facet Osman, Mhdia
Muqbel, Taif
Abduallh, Ahad
Alanazi, Shuruq
Khalifa, Nasrin E.
Khojali, Weam M. A.
Elagib, Halima Mustafa
Hussein, Weiam
Abdallah, Marwa H.
author_sort Osman, Mhdia
collection PubMed
description Background: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has been established that the use of metformin improves the menstrual cycles and ovulation rates of these women. Methods: A structured questionnaire was conducted to determine the prevalence of breast cancer among women using metformin in the Ha’il region. Result: The incidence of breast cancer among women using metformin in the Ha’il region is very low. Thus, it can be said that breast cancer cases declined among diabetics taking metformin. This means that metformin use is associated with a lower risk of breast cancer in women with type 2 diabetes, even in cases where these women have a family history of breast cancer. Conclusions: According to previous findings, metformin has been linked to lower breast cancer risk in women with type 2 diabetes. Furthermore, the findings of this study corroborate the literature on this subject by indicating that there is a substantial connection between metformin use and a lower risk of breast cancer in women with type 2 diabetes. However, further in vitro and in vivo experiments are crucial to investigate the protective effect of metformin against breast cancer and to confirm our findings.
format Online
Article
Text
id pubmed-9914021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99140212023-02-11 Metformin Therapy and Breast Cancer Incidence in the Ha’il Region Osman, Mhdia Muqbel, Taif Abduallh, Ahad Alanazi, Shuruq Khalifa, Nasrin E. Khojali, Weam M. A. Elagib, Halima Mustafa Hussein, Weiam Abdallah, Marwa H. Healthcare (Basel) Article Background: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has been established that the use of metformin improves the menstrual cycles and ovulation rates of these women. Methods: A structured questionnaire was conducted to determine the prevalence of breast cancer among women using metformin in the Ha’il region. Result: The incidence of breast cancer among women using metformin in the Ha’il region is very low. Thus, it can be said that breast cancer cases declined among diabetics taking metformin. This means that metformin use is associated with a lower risk of breast cancer in women with type 2 diabetes, even in cases where these women have a family history of breast cancer. Conclusions: According to previous findings, metformin has been linked to lower breast cancer risk in women with type 2 diabetes. Furthermore, the findings of this study corroborate the literature on this subject by indicating that there is a substantial connection between metformin use and a lower risk of breast cancer in women with type 2 diabetes. However, further in vitro and in vivo experiments are crucial to investigate the protective effect of metformin against breast cancer and to confirm our findings. MDPI 2023-01-20 /pmc/articles/PMC9914021/ /pubmed/36766896 http://dx.doi.org/10.3390/healthcare11030321 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Osman, Mhdia
Muqbel, Taif
Abduallh, Ahad
Alanazi, Shuruq
Khalifa, Nasrin E.
Khojali, Weam M. A.
Elagib, Halima Mustafa
Hussein, Weiam
Abdallah, Marwa H.
Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title_full Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title_fullStr Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title_full_unstemmed Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title_short Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
title_sort metformin therapy and breast cancer incidence in the ha’il region
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914021/
https://www.ncbi.nlm.nih.gov/pubmed/36766896
http://dx.doi.org/10.3390/healthcare11030321
work_keys_str_mv AT osmanmhdia metformintherapyandbreastcancerincidenceinthehailregion
AT muqbeltaif metformintherapyandbreastcancerincidenceinthehailregion
AT abduallhahad metformintherapyandbreastcancerincidenceinthehailregion
AT alanazishuruq metformintherapyandbreastcancerincidenceinthehailregion
AT khalifanasrine metformintherapyandbreastcancerincidenceinthehailregion
AT khojaliweamma metformintherapyandbreastcancerincidenceinthehailregion
AT elagibhalimamustafa metformintherapyandbreastcancerincidenceinthehailregion
AT husseinweiam metformintherapyandbreastcancerincidenceinthehailregion
AT abdallahmarwah metformintherapyandbreastcancerincidenceinthehailregion